Hemotrax Injection 500 mg/5 ml contains Tranexamic Acid, a potent antifibrinolytic agent widely used to prevent and control excessive bleeding in clinical settings. Tranexamic Acid works by inhibiting the conversion of plasminogen to plasmin, an enzyme responsible for breaking down fibrin clots. By stabilizing clots, Hemotrax Injection helps reduce abnormal bleeding while allowing normal coagulation to continue.

This injectable formulation is particularly beneficial when rapid action is required, such as during surgery, trauma, or acute hemorrhage, providing direct and effective control of bleeding. Hemotrax Injection 500 mg/5 ml ensures immediate availability in the bloodstream, making it an essential therapeutic option in hospitals and emergency care.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Hemotrax Injection 500 mg/5 ml is indicated for:

• Prevention and treatment of excessive bleeding during or after surgical procedures

• Management of trauma-related hemorrhage

• Control of heavy menstrual bleeding in acute situations

• Adjunct therapy in patients with hemophilia or other inherited bleeding disorders

• Reduction of bleeding in dental procedures or invasive interventions

This injection is suitable for adult patients and children under the guidance of a healthcare professional. It is especially useful in situations where oral therapy is impractical or too slow.

Dosage and Administration

The dosage of Hemotrax Injection 500 mg/5 ml depends on the severity of bleeding, patient weight, and clinical context:

Typical adult dose:

• 1–1.5 mg/kg body weight administered intravenously slowly over 10–30 minutes

• For ongoing bleeding, additional doses may be repeated according to the physician’s instructions

• In surgical prophylaxis, it may be given preoperatively and repeated postoperatively as needed

Administration guidelines:

• Administer via slow intravenous injection or intravenous infusion

• Ensure the solution is clear and free from particles before use

• Follow aseptic technique to minimize the risk of infection

Dosage adjustments may be required in patients with renal impairment, as tranexamic acid is primarily excreted through the kidneys.

Precautions and Warnings

• Use cautiously in patients with a history of thrombosis, deep vein thrombosis (DVT), pulmonary embolism, or cardiovascular disorders

• Contraindicated in active intravascular clotting or hypersensitivity to tranexamic acid

• Monitor renal function in patients with impaired kidney function

• Avoid rapid intravenous injection to prevent hypotension or other cardiovascular complications

• Pregnant or breastfeeding women should use this medication only under medical supervision

Patients should report any signs of unusual clot formation, severe headache, vision changes, or allergic reactions immediately.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Hemotrax Injection 500 mg/5 ml is generally well tolerated. Possible side effects include:

• Nausea, vomiting, or mild gastrointestinal discomfort

• Dizziness or headache

• Rare allergic reactions such as rash or itching

• Very rarely, thromboembolic events

Proper dosing and monitoring minimize the risk of serious adverse effects.

Storage

Store below 30°C in a dry place, protected from light. Keep out of reach of children. Do not use if the solution appears discolored or contains particles.

Hemotrax Injection 500 mg/5 ml (Tranexamic Acid) provides rapid, effective, and reliable control of excessive bleeding in surgical, traumatic, and clinical settings, ensuring patient safety and optimal hemostasis when used under proper medical supervision.